{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:16:20Z","timestamp":1793661380796,"version":"4.5.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000069","name":"US National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"crossref","award":["2P01 AR-05235"],"award-info":[{"award-number":["2P01 AR-05235"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.bja.2018.06.028","type":"journal-article","created":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T14:06:34Z","timestamp":1534514794000},"page":"944-952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Genetic epidemiology of malignant hyperthermia in the UK"],"prefix":"10.1016","volume":"121","author":[{"given":"D.M.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.M.","family":"Aboelsaod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.J.","family":"Hobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Riasat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.L.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.G.","family":"Bilmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-A.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.M.","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bja.2018.06.028_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/bja\/aer132","article-title":"Malignant hyperthermia \u2013 pharmacology of triggering","volume":"107","author":"Hopkins","year":"2011","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2018.06.028_bib2","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/ALN.0000000000001878","article-title":"Malignant hyperthermia in the post-genomics era: new perspectives on an old concept","volume":"128","author":"Riazi","year":"2018","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2018.06.028_bib3","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/343559a0","article-title":"Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia","volume":"343","author":"MacLennan","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.bja.2018.06.028_bib4","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/343562a0","article-title":"Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2","volume":"342","author":"McCarthy","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.bja.2018.06.028_bib5","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/humu.20356","article-title":"Mutations in ryr1 in malignant hyperthermia and central core disease","volume":"27","author":"Robinson","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1016\/j.bja.2018.06.028_bib6","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/00000542-200606000-00008","article-title":"Malignant hyperthermia in Japan: mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing","volume":"104","author":"Ibarra","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2018.06.028_bib7","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/humu.9442","article-title":"Frequency and localization of mutations in the 106 exons of the RYR1 gene in 50 individuals with malignant hyperthermia","volume":"27","author":"Galli","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1016\/j.bja.2018.06.028_bib8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/0310057X0803600311","article-title":"Identification of genetic mutations in Australian malignant hyperthermia families using sequencing of RYR1 hotspots","volume":"36","author":"Gillies","year":"2008","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.bja.2018.06.028_bib9","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/bja\/aep061","article-title":"Mutation screening of the RYR1-cDNA from peripheral B-lymphocytes in 15 Swedish malignant hyperthermia index cases","volume":"102","author":"Broman","year":"2009","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2018.06.028_bib10","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s12630-011-9494-6","article-title":"Ryanodine receptor type 1 gene mutations found in the Canadian malignant hyperthermia population","volume":"58","author":"Kraeva","year":"2011","journal-title":"Can J Anesth"},{"key":"10.1016\/j.bja.2018.06.028_bib11","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1213\/ANE.0b013e31828a71ff","article-title":"Ryanodine receptor type 1 gene variants in the malignant hyperthermia-susceptible population of the United States","volume":"116","author":"Brandom","year":"2013","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2018.06.028_bib12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/0310057X1504300204","article-title":"Analysis of the entire ryanodine receptor type 1 and alpha 1 subunit of the dihydropyridine receptor (CACNA1S) coding regions for variants associated with malignant hyperthermia in Australian families","volume":"43","author":"Gillies","year":"2015","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.bja.2018.06.028_bib13","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1086\/515454","article-title":"Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle","volume":"60","author":"Monnier","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bja.2018.06.028_bib14","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1471-2350-10-104","article-title":"The role of CACNA1S in predisposition to malignant hyperthermia","volume":"10","author":"Carpenter","year":"2009","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.bja.2018.06.028_bib15","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1073\/pnas.1423113112","article-title":"Stac adaptor proteins regulate trafficking and function of muscle and neuronal L-type Ca2+ channels","volume":"112","author":"Polster","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bja.2018.06.028_bib16","doi-asserted-by":"crossref","first-page":"10986","DOI":"10.1073\/pnas.1612441113","article-title":"Stac3 has a direct role in skeletal muscle-type excitation-contraction coupling that is disrupted by a myopathy-causing mutation","volume":"113","author":"Polster","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bja.2018.06.028_bib17","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1038\/ncomms2952","article-title":"Stac3 is a component of the excitation-contraction coupling machinery and mutated in native American myopathy","volume":"4","author":"Horstick","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.bja.2018.06.028_bib18","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/bja\/aev225","article-title":"The European malignant hyperthermia group guidelines for the investigation of malignant hyperthermia susceptibility","volume":"115","author":"Hopkins","year":"2015","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2018.06.028_bib19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/bja\/aex042","article-title":"Assessing the pathogenicity of RYR1 variants in malignant hyperthermia","volume":"118","author":"Merritt","year":"2017","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2018.06.028_bib20","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/sj.ejhg.5200964","article-title":"Recent advances in the diagnosis of malignant hyperthermia susceptibility: how confident can we be of genetic testing?","volume":"11","author":"Robinson","year":"2003","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.bja.2018.06.028_bib21","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/bja\/56.11.1267","article-title":"A\u00a0protocol for the investigation of malignant hyperpyrexia (MH) susceptibility","volume":"56","author":"European MH Group","year":"1984","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2018.06.028_bib22","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/bja\/57.10.1038","article-title":"Laboratory diagnosis of malignant hyperpyrexia susceptibility (MHS)","volume":"57","author":"European MH Group","year":"1985","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2018.06.028_bib23","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/0888-7543(91)90084-R","article-title":"A\u00a0substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia","volume":"11","author":"Gillard","year":"1991","journal-title":"Genomics"},{"key":"10.1016\/j.bja.2018.06.028_bib24","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1097\/ALN.0000000000000610","article-title":"Next generation sequencing of RYR1 and CACNA1S in malignant hyperthermia and exertional heat illness","volume":"122","author":"Fiszer","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2018.06.028_bib25","first-page":"648","article-title":"An analysis of the predictive probability of the in\u00a0vitro contracture test for determining malignant hyperthermia susceptibility","volume":"84","author":"Hopkins","year":"1997","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2018.06.028_bib26","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ng.2892","article-title":"A\u00a0general framework for estimating the relative pathogenicity of human genetic variants","volume":"46","author":"Kircher","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.bja.2018.06.028_bib27","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/bja\/aew065","article-title":"Comparison of pathogenicity prediction tools on missense variants in RYR1 and CACNA1S associated with malignant hyperthermia","volume":"117","author":"Schiemann","year":"2016","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2018.06.028_bib28","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/mus.21397","article-title":"A\u00a0RYR1 mutation associated with recessive congenital myopathy and dominant malignant hyperthermia in Asian families","volume":"40","author":"Carpenter","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bja.2018.06.028_bib29","doi-asserted-by":"crossref","first-page":"C1094","DOI":"10.1152\/ajpcell.00173.2004","article-title":"Functional analysis of the R1086H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III-IV loop on skeletal muscle EC coupling","volume":"287","author":"Weiss","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.bja.2018.06.028_bib30","doi-asserted-by":"crossref","first-page":"7923","DOI":"10.1073\/pnas.1119207109","article-title":"Malignant hyperthermia susceptibility arising from altered resting coupling between the skeletal muscle L-type Ca2+ channel and the type 1 ryanodine receptor","volume":"109","author":"Eltit","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bja.2018.06.028_bib31","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/ALN.0b013e3182a8a998","article-title":"Exome sequencing reveals novel rare variants in ryanodine receptor and calcium channel genes in malignant hyperthermia families","volume":"119","author":"Kim","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2018.06.028_bib32","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s12630-010-9314-4","article-title":"A\u00a0report of fulminant malignant hyperthermia in a patient with a novel mutation of the CACNA1S gene","volume":"57","author":"Toppin","year":"2010","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.bja.2018.06.028_bib33","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1212\/01.wnl.0000342387.65477.46","article-title":"Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis","volume":"72","author":"Matthews","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.bja.2018.06.028_bib34","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/mus.20068","article-title":"Mutation analysis of two patients with hypokalemic periodic paralysis and suspected malignant hyperthermia","volume":"30","author":"Marchant","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bja.2018.06.028_bib35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/bja\/86.2.283","article-title":"Guidelines for the molecular detection of susceptibility to malignant hyperthermia","volume":"86","author":"Urwyler","year":"2001","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2018.06.028_bib36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.bja.2018.06.028_bib37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature19321","article-title":"Structure of the voltage-gated calcium channel Cav1.1 at 3.6 \u00c5 resolution","volume":"537","author":"Wu","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bja.2018.06.028_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jns.2011.07.046","article-title":"A\u00a0novel mutation in the calcium channel gene in a family with hypokalemic periodic paralysis","volume":"309","author":"Hirano","year":"2011","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.bja.2018.06.028_bib39","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0092-8674(94)90135-X","article-title":"Dihydropyridine receptor mutations cause hypokalemic periodic paralysis","volume":"77","author":"Pt\u00e1cek","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.bja.2018.06.028_bib40","first-page":"374","article-title":"Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): genotype\/phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 Caucasian families","volume":"56","author":"Elbaz","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bja.2018.06.028_bib41","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1093\/brain\/awt300","article-title":"Transient compartment-like syndrome and normokalaemic periodic paralysis due to a Ca(v)1.1 mutation","volume":"136","author":"Fan","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.bja.2018.06.028_bib42","doi-asserted-by":"crossref","first-page":"23217","DOI":"10.1074\/jbc.M804312200","article-title":"The alpha(1S) III-IV loop influences 1,4-dihydropyridine receptor gating but is not directly involved in excitation-contraction coupling interactions with the type 1 ryanodine receptor","volume":"283","author":"Bannister","year":"2008","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.bja.2018.06.028_bib43","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/bja\/aes341","article-title":"Sequence capture and massively parallel sequencing to detect mutations associated with malignant hyperthermia","volume":"110","author":"Schiemann","year":"2013","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2018.06.028_bib44","first-page":"833","article-title":"The G1021A substitution in the RYR1 gene does not always cosegregate with malignant hyperthermia susceptibility in a British pedigree","volume":"60","author":"Adeokun","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bja.2018.06.028_bib45","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/bja\/aep204","article-title":"Genetic variation in RYR1 and malignant hyperthermia phenotypes","volume":"103","author":"Carpenter","year":"2009","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2018.06.028_bib46","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/bja\/70.4.397","article-title":"Comparison of in\u00a0vitro contracture testing with halothane, caffeine and ryanodine in patients with malignant hyperthermia and other neuromuscular disorders","volume":"70","author":"Hopkins","year":"1993","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2018.06.028_bib47","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/bja\/65.5.692","article-title":"Are myotonias and periodic paralyses associated with susceptibility to malignant hyperthermia?","volume":"65","author":"Lehmann-Horn","year":"1990","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2018.06.028_bib48","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/mus.880110507","article-title":"Halothane-caffeine contracture testing in neuromuscular diseases","volume":"11","author":"Heiman-Patterson","year":"1988","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bja.2018.06.028_bib49","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1399-6576.1997.tb04820.x","article-title":"In\u00a0vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects","volume":"41","author":"Ording","year":"1997","journal-title":"Acta Anaesthesiol Scand"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091218305865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091218305865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T23:56:05Z","timestamp":1717199765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091218305865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0007091218305865"],"URL":"https:\/\/doi.org\/10.1016\/j.bja.2018.06.028","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic epidemiology of malignant hyperthermia in the UK","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2018.06.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 British Journal of Anaesthesia. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}